rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sara Nochur

Director

Company insider

Files Form 4 as: Director, City Therapeutics; Director, Marinus Pharmaceuticals; Director, Decibel Therapeutics.

In numbers

Trades disclosed
18
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
22 Mar 2021
Last trade
15 Oct 2026
Last filed
19 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CTY City TherapeuticsDirector · Biotechnology · last 15 Oct 20260 buys · 0 sells
Marinus PharmaceuticalsDirector · last 18 Jun 20240 buys · 0 sells
Decibel TherapeuticsDirector · last 25 Sep 20230 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 19 Oct 2026CTY City Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,649 at $0.00filing
18 Jun 2024filed 20 Jun 2024Marinus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—10,450 at $0.00filing
18 Jun 2024filed 20 Jun 2024Marinus PharmaceuticalsSEC FORM 4 Code A—2,300 at $0.00filing
18 Jan 2024filed 19 Jan 2024Marinus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—20,900 at $0.00filing
18 Jan 2024filed 19 Jan 2024Marinus PharmaceuticalsSEC FORM 4 Code A—4,600 at $0.00filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—10,000filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—5,000filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—20,000filing
25 Sep 2023filed 25 Sep 2023Decibel TherapeuticsSEC FORM 4 Code D—5,000filing
13 Jun 2023filed 14 Jun 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—5,000 at $0.00filing
13 Jun 2023filed 14 Jun 2023Decibel TherapeuticsSEC FORM 4 Code A—5,000 at $0.00filing
26 Jan 2023filed 30 Jan 2023Marinus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—16,200 at $0.00filing
26 Jan 2023filed 30 Jan 2023Marinus PharmaceuticalsSEC FORM 4 Code A—3,600 at $0.00filing
17 Jun 2022filed 21 Jun 2022Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—10,000 at $0.00filing
4 Feb 2022filed 7 Feb 2022Marinus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—12,375 at $0.00filing
4 Feb 2022filed 7 Feb 2022Marinus PharmaceuticalsSEC FORM 4 Code A—2,750 at $0.00filing
3 Dec 2021filed 6 Dec 2021Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
22 Mar 2021filed 24 Mar 2021Marinus Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—33,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John MaraganoreDirector · Director at City Therapeutics, filing Form 4 there in the last year
Robert NelsenDirector and 10% owner · Director and 10% owner at City Therapeutics, filing Form 4 there in the last year
Barry E. GreeneDirector · Director at City Therapeutics, filing Form 4 there in the last year
Andrew C. OrthPresident & CEO · President & CEO at City Therapeutics, filing Form 4 there in the last year
ARCH Venture Partners XII, LLC10% owner · 10% owner at City Therapeutics, filing Form 4 there in the last year